Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vevo Therapeutics—now operating as Tahoe—has developed a proprietary AI-driven drug discovery platform that leverages gigascale single-cell in vivo data to model human cell responses to drugs. Their approach aims to identify novel therapeutics for cancer by capturing patient diversity and biological context at unprecedented scale. The company has generated the world’s largest single-cell atlas for this purpose and has begun advancing discovered candidates toward clinical testing. No published human trial results yet.[1][7]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vevo Therapeutics.